Stockreport

Regeneron and Sanofi's Dupixent shows treatment benefit in adolescents with atopic dermatitis [Seeking Alpha]

Sanofi - American Depositary Shares  (SNY) 
US:NYSE Investor Relations: sanofi.com/en/investors
PDF Regeneron and Sanofi's Dupixent shows treatment benefit in adolescents with atopic dermatitis [Read more]